Published in PLoS Negl Trop Dis on July 20, 2010
Acaricidal activity of eugenol based compounds against scabies mites. PLoS One (2010) 1.11
Complement inhibitors from scabies mites promote streptococcal growth--a novel mechanism in infected epidermis? PLoS Negl Trop Dis (2012) 0.93
Scabies mite peritrophins are potential targets of human host innate immunity. PLoS Negl Trop Dis (2011) 0.92
Scabies mites alter the skin microbiome and promote growth of opportunistic pathogens in a porcine model. PLoS Negl Trop Dis (2014) 0.91
Antibody responses to Sarcoptes scabiei apolipoprotein in a porcine model: relevance to immunodiagnosis of recent infection. PLoS One (2013) 0.88
Prospective study in a porcine model of sarcoptes scabiei indicates the association of Th2 and Th17 pathways with the clinical severity of scabies. PLoS Negl Trop Dis (2015) 0.85
Mitochondrial Genome Sequence of the Scabies Mite Provides Insight into the Genetic Diversity of Individual Scabies Infections. PLoS Negl Trop Dis (2016) 0.82
Quantitative PCR-based genome size estimation of the astigmatid mites Sarcoptes scabiei, Psoroptes ovis and Dermatophagoides pteronyssinus. Parasit Vectors (2012) 0.78
Efficacy assessment of biocides or repellents for the control of Sarcoptes scabiei in the environment. Parasit Vectors (2015) 0.77
Location and pathogenic potential of Blastocystis in the porcine intestine. PLoS One (2014) 0.77
An exploratory study to assess the activity of the acarine growth inhibitor, fluazuron, against Sarcoptes scabei infestation in pigs. Parasit Vectors (2012) 0.77
Prospects for Moxidectin as a New Oral Treatment for Human Scabies. PLoS Negl Trop Dis (2016) 0.76
Genomic resources and draft assemblies of the human and porcine varieties of scabies mites, Sarcoptes scabiei var. hominis and var. suis. Gigascience (2016) 0.75
In vitro activity of ten essential oils against Sarcoptes scabiei. Parasit Vectors (2016) 0.75
Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes - An in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions. PLoS Negl Trop Dis (2017) 0.75
Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model. PLoS Negl Trop Dis (2016) 0.75
In-vitro efficacy of moxidectin versus ivermectin against Sarcoptes scabiei. Antimicrob Agents Chemother (2017) 0.75
A review of Sarcoptes scabiei: past, present and future. Parasit Vectors (2017) 0.75
Host immune responses to the itch mite, Sarcoptes scabiei, in humans. Parasit Vectors (2017) 0.75
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol (2007) 168.76
Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis (2004) 2.33
Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev (2007) 1.81
Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. Bull World Health Organ (2008) 1.51
High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis (2009) 1.35
Scabies: new future for a neglected disease. Adv Parasitol (2004) 1.29
Networks in phylogenetic analysis: new tools for population biology. Int J Parasitol (2005) 1.23
Genetic epidemiology of Sarcoptes scabiei (Acari: Sarcoptidae) in northern Australia. Int J Parasitol (2004) 1.19
Scabies mite inactivated serine protease paralogs inhibit the human complement system. J Immunol (2009) 1.11
Community management of endemic scabies in remote aboriginal communities of northern Australia: low treatment uptake and high ongoing acquisition. PLoS Negl Trop Dis (2009) 1.11
Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol (2008) 1.10
Mechanisms for a novel immune evasion strategy in the scabies mite sarcoptes scabiei: a multigene family of inactivated serine proteases. J Invest Dermatol (2003) 1.10
New insights into disease pathogenesis in crusted (Norwegian) scabies: the skin immune response in crusted scabies. Br J Dermatol (2008) 1.07
Cross infestivity of Sarcoptes scabiei. J Am Acad Dermatol (1984) 1.06
Generation and characterization of cDNA clones from Sarcoptes scabiei var. hominis for an expressed sequence tag library: identification of homologues of house dust mite allergens. Am J Trop Med Hyg (2003) 1.03
Experimental Sarcoptes scabiei infestation in pigs: (1) pathogenesis. Vet Rec (1979) 1.03
High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Med Vet Entomol (2008) 0.97
Scabies mite inactivated serine protease paralogues are present both internally in the mite gut and externally in feces. Am J Trop Med Hyg (2006) 0.95
Dynamics of swine mange: a critical review of the literature. J Med Entomol (1990) 0.95
Increased transcription of Glutathione S-transferases in acaricide exposed scabies mites. Parasit Vectors (2010) 0.95
Structural mechanisms of inactivation in scabies mite serine protease paralogues. J Mol Biol (2009) 0.94
Immunoblot analysis of IgG antibody response to Sarcoptes scabiei in swine. Vet Immunol Immunopathol (2006) 0.92
Normalization of a cDNA library cloned in lambda ZAP by a long PCR and cDNA reassociation procedure. Biotechniques (2003) 0.91
Pathway-specific complement activity in pigs evaluated with a human functional complement assay. Mol Immunol (2009) 0.90
Crusted scabies: A molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis (1999) 0.90
Scabies. Dermatol Clin (1990) 0.89
Epidemiological problems of scabies. Int J Dermatol (1978) 0.88
Systemic activation of coagulation and fibrynolysis in a porcine model of serogroup A streptococcal shock. Blood Coagul Fibrinolysis (2000) 0.88
Sarcoptic mange and production performance of swine: a review of the literature and studies of associations between mite infestation, growth rate and measures of mange severity in growing pigs. Vet Parasitol (1995) 0.87
Characterization of a serine protease homologous to house dust mite group 3 allergens from the scabies mite Sarcoptes scabiei. J Biol Chem (2009) 0.85
Similar epidermal changes in hyperkeratotic scabies of humans and pigs. Am J Dermatopathol (1986) 0.84
Paramyosin from the parasitic mite Sarcoptes scabiei: cDNA cloning and heterologous expression. Parasitology (2001) 0.84
Crusted (Norwegian) scabies induced by use of topical corticosteroids and treated successfully with ivermectin. J Pediatr (1999) 0.82
Effects of dexamethasone on peripheral blood mononuclear cell phenotype in weanling piglets. Comp Immunol Microbiol Infect Dis (2005) 0.81
On the substantial variation in serological responses in pigs to Sarcoptes scabiei var. suis using different commercially available indirect enzyme-linked immunosorbent assays. Parasitol Res (2004) 0.80
Effects of sarcoptic mange on lactating swine and growing pigs. J Anim Sci (1990) 0.79
Scanning electron microscopy of sarcoptic mange lesions in swine. Vet Parasitol (1989) 0.79
Responses of immunoglobulin-secreting cells in the skin of pigs during Sarcoptes scabiei infestation. Vet Parasitol (1989) 0.78
Analysis of Sarcoptes scabiei finds no evidence of infection with Wolbachia. Int J Parasitol (2004) 0.77
Antiretrovirals as antimalarial agents. J Infect Dis (2004) 3.60
A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One (2010) 3.50
Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic. PLoS Negl Trop Dis (2011) 2.81
Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev (2007) 2.50
A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis (2012) 2.28
Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells. Hepatology (2013) 2.12
A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis (2012) 2.09
Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol (2009) 1.96
A comparison of the sensitivity and fecal egg counts of the McMaster egg counting and Kato-Katz thick smear methods for soil-transmitted helminths. PLoS Negl Trop Dis (2011) 1.81
Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J (2010) 1.77
Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation (2014) 1.76
Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrob Agents Chemother (2006) 1.72
Permethrin and ivermectin for scabies. N Engl J Med (2010) 1.71
Effect of antimalarial drugs on Plasmodium falciparum gametocytes. J Infect Dis (2009) 1.59
pfcrt Allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob Agents Chemother (2003) 1.59
Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. Antimicrob Agents Chemother (2004) 1.52
Immune reconstitution syndrome to Strongyloides stercoralis syndrome: authors' response. AIDS (2007) 1.42
Outcomes of repair of complete atrioventricular septal defect in the current era. Eur J Cardiothorac Surg (2013) 1.39
Transcription and expression of Plasmodium falciparum histidine-rich proteins in different stages and strains: implications for rapid diagnostic tests. PLoS One (2011) 1.35
Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial. PLoS One (2011) 1.30
Scabies: new future for a neglected disease. Adv Parasitol (2004) 1.29
A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility. PLoS Negl Trop Dis (2010) 1.28
A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl Trop Dis (2012) 1.27
A research agenda for helminth diseases of humans: towards control and elimination. PLoS Negl Trop Dis (2012) 1.26
Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis (2013) 1.23
Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malar J (2010) 1.23
Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy. Trans R Soc Trop Med Hyg (2006) 1.23
Antimalarial activity of sera from subjects taking HIV protease inhibitors. AIDS (2007) 1.23
Origin and dissemination of chloroquine-resistant Plasmodium falciparum with mutant pfcrt alleles in the Philippines. Antimicrob Agents Chemother (2005) 1.21
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Clin Pharmacol Ther (2002) 1.21
Organization of ETRAMPs and EXP-1 at the parasite-host cell interface of malaria parasites. Mol Microbiol (2006) 1.20
A cluster of ring stage-specific genes linked to a locus implicated in cytoadherence in Plasmodium falciparum codes for PEXEL-negative and PEXEL-positive proteins exported into the host cell. Mol Biol Cell (2006) 1.20
Speed cameras for the prevention of road traffic injuries and deaths. Cochrane Database Syst Rev (2010) 1.16
Widespread contribution of methane-cycle bacteria to the diets of lake profundal chironomid larvae. Ecology (2008) 1.14
Identification of optimal epitopes for Plasmodium falciparum rapid diagnostic tests that target histidine-rich proteins 2 and 3. J Clin Microbiol (2012) 1.13
Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog (2012) 1.13
Scabies mite inactivated serine protease paralogs inhibit the human complement system. J Immunol (2009) 1.11
Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transpl (2003) 1.11
Circulating IgE in patients with ordinary and crusted scabies. J Med Entomol (2004) 1.11
Laboratory demonstration of a prozone-like effect in HRP2-detecting malaria rapid diagnostic tests: implications for clinical management. Malar J (2011) 1.10
Carriage of methicillin-resistant Staphylococcus aureus in a Queensland Indigenous community. Med J Aust (2006) 1.10
Scratching the itch: new tools to advance understanding of scabies. Trends Parasitol (2012) 1.10
A novel Plasmodium falciparum ring stage protein, REX, is located in Maurer's clefts. Mol Biochem Parasitol (2004) 1.10
Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One (2011) 1.10
Mechanisms for a novel immune evasion strategy in the scabies mite sarcoptes scabiei: a multigene family of inactivated serine proteases. J Invest Dermatol (2003) 1.10
Experimentally induced blood stage malaria infection as a tool for clinical research. Trends Parasitol (2012) 1.09
Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss. Am J Pathol (2009) 1.07
Generation and characterization of cDNA clones from Sarcoptes scabiei var. hominis for an expressed sequence tag library: identification of homologues of house dust mite allergens. Am J Trop Med Hyg (2003) 1.03
Application of in vitro anthelmintic sensitivity assays to canine parasitology: detecting resistance to pyrantel in Ancylostoma caninum. Vet Parasitol (2008) 1.02
Malaria infection alters the expression of B-cell activating factor resulting in diminished memory antibody responses and survival. Eur J Immunol (2012) 1.02
Novel scabies mite serpins inhibit the three pathways of the human complement system. PLoS One (2012) 1.02
Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors. Antimicrob Agents Chemother (2009) 1.01
Parasitism may enhance rather than reduce the predatory impact of an invader. Biol Lett (2010) 1.01
The effects of different plant extracts on intestinal cestodes and on trematodes. Parasitol Res (2010) 1.00
Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands". J Neuroimmunol (2009) 1.00
Case report: nitazoxanide for treatment of refractory bony hydatid disease. Am J Trop Med Hyg (2009) 0.99
Rhizomycosis infection in the basal ganglia. Arch Neurol (2007) 0.98
Oxantel pamoate-albendazole for Trichuris trichiura infection. N Engl J Med (2014) 0.97
Ten families of variant genes encoded in subtelomeric regions of multiple chromosomes of Plasmodium chabaudi, a malaria species that undergoes antigenic variation in the laboratory mouse. Mol Microbiol (2003) 0.97
The effects of different plant extracts on nematodes. Parasitol Res (2010) 0.97
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study. Antimicrob Agents Chemother (2011) 0.96
Increased transcription of Glutathione S-transferases in acaricide exposed scabies mites. Parasit Vectors (2010) 0.95
Anthelmintic activity of cyclotides: In vitro studies with canine and human hookworms. Acta Trop (2008) 0.95
Scabies mite inactivated serine protease paralogues are present both internally in the mite gut and externally in feces. Am J Trop Med Hyg (2006) 0.95
The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment. PLoS One (2012) 0.95
Structural mechanisms of inactivation in scabies mite serine protease paralogues. J Mol Biol (2009) 0.94
High-level pyrantel resistance in the hookworm Ancylostoma caninum. Vet Parasitol (2006) 0.94
Plasmodium falciparum: new molecular targets with potential for antimalarial drug development. Expert Rev Anti Infect Ther (2009) 0.94
An improved method for undertaking limiting dilution assays for in vitro cloning of Plasmodium falciparum parasites. Malar J (2011) 0.93
Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities. Arch Dermatol (2009) 0.93
Complement inhibitors from scabies mites promote streptococcal growth--a novel mechanism in infected epidermis? PLoS Negl Trop Dis (2012) 0.93
Scabies mite peritrophins are potential targets of human host innate immunity. PLoS Negl Trop Dis (2011) 0.92
Identification and characterization of Sarcoptes scabiei and Dermatophagoides pteronyssinus glutathione S-transferases: implication as a potential major allergen in crusted scabies. Am J Trop Med Hyg (2005) 0.92
Parasitic diseases of remote Indigenous communities in Australia. Int J Parasitol (2010) 0.91
Implication of a Plasmodium falciparum gene in the switch between asexual reproduction and gametocytogenesis. Mol Biochem Parasitol (2005) 0.90
A coproantigen diagnostic test for Strongyloides infection. PLoS Negl Trop Dis (2011) 0.90
Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis (2006) 0.89
Acetylcholine receptor subunit genes from Ancylostoma caninum: altered transcription patterns associated with pyrantel resistance. Int J Parasitol (2008) 0.89
Low-level Plasmodium falciparum blood-stage infection causes dendritic cell apoptosis and dysfunction in healthy volunteers. J Infect Dis (2012) 0.89
Modelling the dynamics of Plasmodium falciparum histidine-rich protein 2 in human malaria to better understand malaria rapid diagnostic test performance. Malar J (2012) 0.89
Antibody responses to Sarcoptes scabiei apolipoprotein in a porcine model: relevance to immunodiagnosis of recent infection. PLoS One (2013) 0.88
A multigene family of inactivated cysteine proteases in Sarcoptes scabiei. J Invest Dermatol (2004) 0.88
Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage. Exp Neurol (2009) 0.87
PCR-based assay to survey for knockdown resistance to pyrethroid acaricides in human scabies mites (Sarcoptes scabiei var hominis). Am J Trop Med Hyg (2006) 0.87
Induction of peroxiredoxin I gene expression by LPS involves the Src/PI3K/JNK signalling pathway. Biochim Biophys Acta (2009) 0.87
Circulating antibodies against Plasmodium falciparum histidine-rich proteins 2 interfere with antigen detection by rapid diagnostic tests. Malar J (2014) 0.87